MENU

Fox Chase Cancer Center News

Paul F. Engstrom, MD, FACP, and his role as a pioneer in tCancer Prevention Research,.
April 27, 2020

Fox Chase Researchers Launch Special Series Honoring Paul F. Engstrom, MD

PHILADELPHIA (April 27, 2020) – Researchers at Fox Chase Cancer Center recently published a series of articles in Cancer Prevention Research, a journal of the American Association for Cancer Research, honoring Paul F. Engstrom, MD, FACP, and his role as a pioneer in the field.

The Pennsylvania Medical Society (PAMED) released its list of this year’s Top Physicians Under 40.
April 27, 2020

Two Fox Chase Cancer Center Doctors Named ‘Top Physicians Under 40’ in Pennsylvania

PHILADEPHIA (April 27, 2020) – Two Fox Chase Cancer Center doctors were honored by PAMED: Sanjay S. Reddy, MD, FACS, associate professor in the Department of Surgical Oncology, and Namrata “Neena” Vijayvergia, MD, assistant chief of gastrointestinal medical oncology in the Department of Hematology/Oncology.

Christian Koch, MD, PhD, FACP, MACE
April 24, 2020

Fox Chase Physician Named Editor for Cancer Journal

PHILADELPHIA (April 24, 2020) – Christian Koch, MD, PhD, FACP, MACE, a professor in the Department of Medicine and director for the Division of Endocrinology at Fox Chase Cancer Center, was recently named a review editor for Frontiers in Cancer Endocrinology, a specialty section in the journal Frontiers in Endocrinology.

Israel Cañadas, PhD
April 23, 2020

Fox Chase Researcher Receives Grant to Study Lung Cancer Environment and Vulnerabilities

PHILADELPHIA (April 23, 2020)— The grant was awarded to Israel Cañadas, PhD by the Lung Cancer Research Foundation to study how different cancer cells within a tumor may affect the environment around it and the tumor’s response to therapy.

Senior author Robert G. Uzzo, MD, MBA, FACS
April 21, 2020

Clinical Trial for Everolimus Shows Decreased Tumor Volume for Patients With Benign Kidney Tumors

PHILADELPHIA (April 21, 2020)—A clinical trial headed by Fox Chase Cancer Center physicians has found that patients with certain common benign, spontaneous kidney tumors saw a marked decrease in tumor volume after being treated with the drug everolimus, also known by its brand name, Afinitor. Until this study, there were no data on whether the drug was effective and safe for patients with the tumors who don’t have angiomyolipomas.

Namrata Vijayvergia, MD
April 20, 2020

Fox Chase Receives Grant to Study Variations in Imaging Techniques for Pancreatic Neuroendocrine Tumors

PHILADELPHIA (April, 20, 2020)—Researchers at Fox Chase Cancer Center were recently awarded a federally funded grant to study variability in scans for pancreatic neuroendocrine tumor (NET) patients. With repurposing of these imaging studies, which were obtained as a part of a clinical trial funded by the National Cancer Institute, researchers could begin developing solutions to these barriers.

Jessica Bauman, MD
April 17, 2020

Fox Chase Researcher Receives Grant to Study Implementation of Nutrition Plans for Lung Cancer Patients

PHILADELPHIA (April 17, 2020) — A  $2.3 million grant for a multicenter randomized clinical trial to study the use of medically tailored meals and individually-tailored nutrition counseling as part of care for lung cancer patients will enroll 150 newly diagnosed stage I-IV lung cancer patients from vulnerable populations, including those who are uninsured, economically disadvantaged, older adults, rural residents or racial/ethnic minorities.

Dr. Alexander Kutikov
April 15, 2020

International Collaboration Facilitates Fox Chase Researcher’s Study on Partial Nephrectomy Resection Technique

PHILADELPHIA (April 15, 2020) – A study on partial nephrectomy techniques by Alexander Kutikov, MD, FACS, was recently published after years of collaboration involving centers in the United States and Europe. The study examined how the resection technique used during partial nephrectomy might affect operative outcomes and surgical margins

Pages

Connect with Fox Chase